BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 15106303)

  • 21. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 22. Fixed dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV infection: a preliminary report.
    Pensi T
    Indian Pediatr; 2007 Jul; 44(7):519-21. PubMed ID: 17684304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

  • 24. AIDS. Resource needs for HIV/AIDS.
    Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
    Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
    [No Abstract]   [Full Text] [Related]  

  • 25. Access for all?
    Lange JM; Thaineua V
    Science; 2004 Jun; 304(5679):1875. PubMed ID: 15218109
    [No Abstract]   [Full Text] [Related]  

  • 26. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract]   [Full Text] [Related]  

  • 28. Public health. A global response to AIDS: lessons learned, next steps.
    Piot P; Feachem RG; Lee JW; Wolfensohn JD
    Science; 2004 Jun; 304(5679):1909-10. PubMed ID: 15218129
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV/AIDS. Treatment and prevention exchange vows at international conference.
    Cohen J
    Science; 2008 Aug; 321(5891):902-3. PubMed ID: 18703717
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV/AIDS: Latin America & Caribbean. Overview: the overlooked epidemic.
    Cohen J
    Science; 2006 Jul; 313(5786):468-9. PubMed ID: 16873639
    [No Abstract]   [Full Text] [Related]  

  • 32. Double standards in research ethics, health-care safety, and scientific rigour allowed Africa's HIV/AIDS epidemic disasters.
    Gisselquist D
    Int J STD AIDS; 2009 Dec; 20(12):839-45. PubMed ID: 19948898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
    Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
    Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WHO takes major steps to make HIV treatment accessible.
    J Adv Nurs; 2002 Sep; 39(6):517-8. PubMed ID: 12365403
    [No Abstract]   [Full Text] [Related]  

  • 35. [To finish theoretically with AIDS].
    Nau JY
    Rev Med Suisse; 2008 Dec; 4(183):2705. PubMed ID: 19157288
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.
    Zala C; Salomón H; Cahn P
    Antivir Ther; 1999; 4 Suppl 3():95-9. PubMed ID: 16021880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-five years of HIV/AIDS.
    Fauci AS
    Science; 2006 Jul; 313(5786):409. PubMed ID: 16873613
    [No Abstract]   [Full Text] [Related]  

  • 38. [Future possibilities of drug therapy of acquired immunodeficiency syndrome].
    Bálint GS
    Orv Hetil; 1994 Jun; 135(23):1235-42. PubMed ID: 8015818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
    Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deaths bring South African HIV drug trials to a premature halt.
    Cherry M
    Nature; 2000 Apr; 404(6779):695. PubMed ID: 10783859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.